Summit Healthcare Acquisition Corp.

NasdaqCM:SMIH Stock Report

Mkt Cap: US$334.8m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Summit Healthcare Acquisition Management

Management criteria checks 0/4

Key information

Bo Tan

Chief executive officer


Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure1.8yrs

Recent management updates

No updates

Recent updates


Bo Tan (49 yo)

no data


Mr. Bo Tan was an Independent Non-Executive Director at Everest Medicines Limited since September 25, 2020 until January 19, 2023. He has been a Director at Akeso, Inc. (HKEX: 9926) since April 2020. Mr. T...

Board Members

Bo Tan
CEO, Co-Chief Investment Officer & Directorno datano datano data
Cho Fai Poon
Presidentno datano datano data
Ian Charles Stone
Independent Director1.8yrsno datano data
Thomas Folinsbee
Independent Director1.8yrsno datano data
Tao Bai
Independent Director1.8yrsno datano data


Average Tenure


Average Age

Experienced Board: SMIH's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.